|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||
1 RMIT
2 WCMC-Q
* To whom correspondence should be addressed. E-mail: hod2005{at}qatar-med.cornell.edu.
Hyperglycemia is a major risk factor for endothelial dysfunction and vascular disease and, in the current study, the link to glucose-induced abnormal intracellular calcium (Ca2+i) homeostasis was explored in bovine aortic endothelial cells (BAECs) in high glucose (HG) (25 mmol/L) versus control (low glucose, LG) (5.5 mmol/L). Transient receptor potential 1 (TRPC1) ion channel protein, but not TRPC3, TRPC4 or TRPC6 expression, was significantly increased in HG vs. LG at 72 h. HG for 4, 24 and 72 h did not change basal Ca2+i or ATP-induced Ca2+i release, however, the amplitude of sustained Ca2+i was significantly increased at 24 and 72 h and reduced by low concentration of the putative, but non-specific, TRPC blockers, gadolinium (Gd3+), SKF96365 and 2-aminoethoxydiphenyl borate (2-APB). Treatment with TRPC1 antisense significantly reduced TRPC1 protein expression and ATP-induced Ca2+ entry in BAECs. Although the link between HG-induced changes in TRPC1 expression, enhanced Ca2+ entry and endothelial dysfunction requires further study, the current data are suggestive that targeting these pathways may reduce the impact of HG on endothelial function.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |